Search Within

Autumn S Mcdonnell

Formats
  1. Meeting Abstract (3)
  2. Journal Article (2)
Groups
  1. Department of Medicine (5)
  2. GDMT, Medicine (5)
  3. Gynecologic Medicine Service (5)
  4. Gynecology Disease Management Team (5)
  5. Hematologic Malignancies, Division of (5)
  6. Solid Tumor Oncology Division (5)

More Groups

People
  1. Carol Aghajanian (5)
  2. Dmitriy Zamarin (5)
  3. Rachel Grisham (5)
  4. Roisin O'Cearbhaill (5)
  5. Alexia Iasonos (4)
  6. Qin Zhou (4)

More People

Years
  1. 2022 (1)
  2. 2020 (2)
  3. 2019 (2)
Publications
  1. Gynecologic Oncology (2)
  2. Clinical Cancer Research (1)
  3. International Journal of Gynecological Cancer (1)
  4. Journal for ImmunoTherapy of Cancer (1)
Publishers
  1. Elsevier Inc. (2)
  2. American Association for Cancer Research (1)
  3. Biomed Central Ltd (1)
  4. Lippincott Williams & Wilkins (1)

Results (5)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II study of enzalutamide in androgen receptor positive, recurrent, high- and low-grade serous ovarian cancer
    Journal Article

    Manning-Geist, B. L.; Gordhandas, S. B.; Giri, D. D.; Iasonos, A.; Zhou, Q.; Girshman, J.; O'Cearbhaill, R. E.; Zamarin, D.; Lichtman, S. M.; Sabbatini, P. J.; more...
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • Phase II study of enzalutamide in androgen receptor positive (AR+) recurrent high-grade and low-grade serous ovarian cancer
    Meeting Abstract

    Grisham, R. N.; Giri, D. D.; McDonnell, A.; Iasonos, A.; Zhou, Q.; Li, K.; Girshman, J.; O'Cearbhaill, R. E.; Zamarin, D.; Aghajanian, C.
    Gynecologic Oncology (2020)

    Fulltext@MSK | Save
  • Safety, immunogenicity, and clinical efficacy of durvalumab in combination with folate receptor alpha vaccine TPIV200 in patients with advanced ovarian cancer: A phase II trial
    Journal Article

    Zamarin, D.; Walderich, S.; Holland, A.; Zhou, Q.; Iasonos, A. E.; Torrisi, J. M.; Merghoub, T.; Chesebrough, L. F.; Mcdonnell, A. S.; Gallagher, J. M.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • A phase 2 study of TPIV200/ huFR-1 (a multi-epitope folate receptor alpha vaccine) in combination with durvalumab in patients with platinum resistant ovarian cancer
    Meeting Abstract

    Zamarin, D.; Yeku, O.; O'Cearbhaill, R. E.; Cadoo, K. A.; Gallagher, J.; Kravetz, S.; McDonnell, A.; Troso-Sandoval, T.; Sabbatini, P.; Lichtman, S.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Phase II study of enzalutamide in androgen receptor positive (AR+) recurrent ovarian cancer: Final results
    Meeting Abstract

    Grisham, R.; Giri, D.; Henson, M.; Iasonos, A.; Zhou, Q.; McDonnell, A.; Girshman, J.; O'Cearbhaill, R.; Zamarin, D.; Aghajanian, C.
    International Journal of Gynecological Cancer (2019)

    Fulltext@MSK | Save